Our laboratory performs translational research on the cellular and molecular mechanisms, and signaling pathways, regulating bone metabolism, and their implication in bone fragility. We are particularly interested in the function and regulation of the WNT/beta-catenin and PDGFR signaling pathways on bone formation and resorption, and in the mechanisms of action and effects of sclerostin inhibitors thereon.
